Ming Pan

This inventor holds 9 USPTO granted patents, plus 5 CIPO patents and 4 EPO patents. Top assignees: Alphora Research Inc., Sandoz Ag. Active years: 2008-2019.

USPTO Granted Patents = 9

% Patents Active = 33.3

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 23(Granted Patents)

Company Filing History:

7 out of 18

Alphora Research Inc.

Years Active: 2008-2019

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10301274 - Crystalline derivatives of (S)-1-((2R,3R,4S,5S)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-YL)-3-aminopropan-2-ol (2019-05-28),

2. 9850254 - [object Object] (2017-12-26),

3. 9695187 - Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein (2017-07-04),

4. 9278979 - Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein (2016-03-08),

5. 9181152 - [object Object] (2015-11-10),

6. 9062020 - 2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation (2015-06-23),

7. 8013176 - Paricalcitol purification (2011-09-06),

8. 7795459 - Paricalcitol purification (2010-09-14),

9. 7323576 - Synthetic route to dronabinol (2008-01-29),

Title: The Innovative Contributions of Ming Pan

Introduction

Ming Pan is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His work focuses on the development of compounds that have potential therapeutic applications.

Latest Patents

Ming Pan's latest patents include innovative crystalline derivatives of (S)-1-((2R,3R,4S,5S)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-YL)-3-aminopropan-2-ol. These patents disclose salts of a compound of formula 1, which can be useful for the preparation of halichondrin analogs such as eribulin. Additionally, he has disclosed a process for the preparation of these salts and the intermediates used in their synthesis.

Career Highlights

Throughout his career, Ming Pan has worked with prominent companies in the pharmaceutical industry, including Alphora Research Inc. and Sandoz AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.

Collaborations

Ming Pan has collaborated with several professionals in his field, including Fabio E S Souza and Boris Gorin. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Ming Pan's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of important therapeutic compounds.